David-Alexandre C. Gros

Insider Reports History

Location
Boston, MA
Signature
/s/ Paul Little, as attorney-in-fact for David Alexandre C. Gros, M.D.
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David-Alexandre C. Gros:

Company Role Class Num Shares Value Price $ Report Date Ownership
Eledon Pharmaceuticals, Inc. Chief Executive Officer, Director Stock Option (right to buy) 600,000 $1,574,402 $1.55 10 Jan 2025 Direct
Eledon Pharmaceuticals, Inc. Chief Executive Officer, Director Restricted Stock Units 66,500 10 Jan 2025 Direct

Insider Reports Filed by David-Alexandre C. Gros

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ELDN Eledon Pharmaceuticals, Inc. 10 Jan 2025 2 $0 4 Chief Executive Officer, Director 13 Jan 2025, 17:30
ELDN Eledon Pharmaceuticals, Inc. 21 Nov 2024 1 $0 4 Chief Executive Officer, Director 22 Nov 2024, 17:00
ELDN Eledon Pharmaceuticals, Inc. 13 Jun 2024 1 $0 4 Chief Executive Officer, Director 14 Jun 2024, 17:00
ELDN Eledon Pharmaceuticals, Inc. 01 May 2023 1 $0 4 Chief Executive Officer, Director 02 May 2023, 18:49
ELDN Eledon Pharmaceuticals, Inc. 01 Feb 2023 2 $0 4 Chief Executive Officer, Director 02 Feb 2023, 16:56
ELDN Eledon Pharmaceuticals, Inc. 01 Feb 2022 1 $0 4 Chief Executive Officer, Director 02 Feb 2022, 16:38
ELDN Eledon Pharmaceuticals, Inc. 20 Dec 2021 1 +$8,960 4 Chief Executive Officer, Director 21 Dec 2021, 15:05
ELDN Eledon Pharmaceuticals, Inc. 17 Aug 2021 1 +$24,840 4 Chief Executive Officer, Director 19 Aug 2021, 16:05
ELDN Eledon Pharmaceuticals, Inc. 09 Jun 2021 1 +$24,030 4 Chief Executive Officer, Director 10 Jun 2021, 17:25